The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better...

Following the success of the first collection of Stahl's Case Studies, published in 2011, we are pleased to present this completely new selection of clinical stories. Designed with the distinctive user-friendly presentation readers have become accustomed to and making use of icons, questions/answers and tips, these cases address complex issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to...

This book focuses on violence from assessment, through underlying neurobiology, to treatment and other recommendations for practice.

A spin-off of the best-selling Stahl's Prescriber's Guide, covering the most important drugs for treating patients with psychotic illness.

Describing the most common causes of dementia, this book reviews best practices for differentially diagnosing dementia and covers effective management strategies. Visual learners will find that this book makes the concepts easier to master and non-visual learners will appreciate the clear, shortened text on complex psychopharmacological concepts.